Lymphocyte Predominant Hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2008-08-12
Clinical Trial Update: Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL) [Phase 2]
Phase 2 clinical trial of Rituximab for Lymphocyte Predominant Hodgkin's Lymphoma (LPHD) has completed. The study is associated with the Uni…